RU2013101020A - Вакцины на основе модифицированного вируса гриппа - Google Patents
Вакцины на основе модифицированного вируса гриппа Download PDFInfo
- Publication number
- RU2013101020A RU2013101020A RU2013101020/10A RU2013101020A RU2013101020A RU 2013101020 A RU2013101020 A RU 2013101020A RU 2013101020/10 A RU2013101020/10 A RU 2013101020/10A RU 2013101020 A RU2013101020 A RU 2013101020A RU 2013101020 A RU2013101020 A RU 2013101020A
- Authority
- RU
- Russia
- Prior art keywords
- influenza
- virus
- molecule
- vaccine
- amino acid
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract 15
- 241000712461 unidentified influenza virus Species 0.000 title claims abstract 7
- 241000712431 Influenza A virus Species 0.000 claims abstract 8
- 235000001014 amino acid Nutrition 0.000 claims abstract 8
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims abstract 6
- 229940024606 amino acid Drugs 0.000 claims abstract 6
- 150000001413 amino acids Chemical class 0.000 claims abstract 6
- 229960001230 asparagine Drugs 0.000 claims abstract 6
- 235000009582 asparagine Nutrition 0.000 claims abstract 6
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims abstract 4
- 238000006467 substitution reaction Methods 0.000 claims abstract 4
- 101710154606 Hemagglutinin Proteins 0.000 claims abstract 2
- 229940124873 Influenza virus vaccine Drugs 0.000 claims abstract 2
- 241001465754 Metazoa Species 0.000 claims abstract 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims abstract 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims abstract 2
- 101710176177 Protein A56 Proteins 0.000 claims abstract 2
- 241000700605 Viruses Species 0.000 claims abstract 2
- 230000013595 glycosylation Effects 0.000 claims abstract 2
- 238000006206 glycosylation reaction Methods 0.000 claims abstract 2
- 239000000185 hemagglutinin Substances 0.000 claims abstract 2
- 208000037797 influenza A Diseases 0.000 claims abstract 2
- 229960003971 influenza vaccine Drugs 0.000 claims abstract 2
- 230000009257 reactivity Effects 0.000 claims abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/11—Orthomyxoviridae, e.g. influenza virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
1. Вакцина против вируса гриппа А субтипа Н5, где указанная вакцина включает рекомбинантную молекулу гемагглютинина гриппа А субтипа Н5 (НА Н5), обладающую реактивностью в отношении антисыворотки, полученной из организма животного, которое инфицировано вирусом гриппа или противогриппозной вакциной и включающая аминокислоту аспарагин в положении, соответствующем положению 223 в НА Н5, где молекула НА не происходит из изолята человеческого Н5 А/НК/213/03.2. Вакцина по п.1, где рекомбинантная молекула НА содержит одну или несколько замен по сравнению с соответствующей молекулой НА дикого типа, причем указанная молекула НА включает аминокислоту аспарагин в положении, соответствующем положению 223 в НА Н5, а указанная молекула дикого типа включает аминокислоту, отличную от аспарагина, в положении, соответствующем положению 223.3. Вакцина по п.1, где аминокислотная замена в рекомбинантной молекуле НА вируса гриппа приводит к изменению сайта гликозилирования.4. Вакцина по п.1, где вирус гриппа представляет собой вирус гриппа А человека.5. Вакцина по п.4, где вирус гриппа А человека является представителем Н5-субтипа.6. Вакцина по п.4, где вирус гриппа А человека представляет собой вирус A/Vietnam/1203/04 (H5N1).
Claims (6)
1. Вакцина против вируса гриппа А субтипа Н5, где указанная вакцина включает рекомбинантную молекулу гемагглютинина гриппа А субтипа Н5 (НА Н5), обладающую реактивностью в отношении антисыворотки, полученной из организма животного, которое инфицировано вирусом гриппа или противогриппозной вакциной и включающая аминокислоту аспарагин в положении, соответствующем положению 223 в НА Н5, где молекула НА не происходит из изолята человеческого Н5 А/НК/213/03.
2. Вакцина по п.1, где рекомбинантная молекула НА содержит одну или несколько замен по сравнению с соответствующей молекулой НА дикого типа, причем указанная молекула НА включает аминокислоту аспарагин в положении, соответствующем положению 223 в НА Н5, а указанная молекула дикого типа включает аминокислоту, отличную от аспарагина, в положении, соответствующем положению 223.
3. Вакцина по п.1, где аминокислотная замена в рекомбинантной молекуле НА вируса гриппа приводит к изменению сайта гликозилирования.
4. Вакцина по п.1, где вирус гриппа представляет собой вирус гриппа А человека.
5. Вакцина по п.4, где вирус гриппа А человека является представителем Н5-субтипа.
6. Вакцина по п.4, где вирус гриппа А человека представляет собой вирус A/Vietnam/1203/04 (H5N1).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70580805P | 2005-08-04 | 2005-08-04 | |
US60/705,808 | 2005-08-04 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011103648/10A Division RU2480480C2 (ru) | 2005-08-04 | 2006-07-28 | Способы применения модифицированного вируса гриппа |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013101020A true RU2013101020A (ru) | 2014-07-20 |
RU2552213C2 RU2552213C2 (ru) | 2015-06-10 |
Family
ID=37727844
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011103648/10A RU2480480C2 (ru) | 2005-08-04 | 2006-07-28 | Способы применения модифицированного вируса гриппа |
RU2008107875/10A RU2420535C2 (ru) | 2005-08-04 | 2006-07-28 | Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины |
RU2013101020/10A RU2552213C2 (ru) | 2005-08-04 | 2013-01-11 | Вакцины на основе модифицированного вируса гриппа |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011103648/10A RU2480480C2 (ru) | 2005-08-04 | 2006-07-28 | Способы применения модифицированного вируса гриппа |
RU2008107875/10A RU2420535C2 (ru) | 2005-08-04 | 2006-07-28 | Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины |
Country Status (16)
Country | Link |
---|---|
US (4) | US7871626B2 (ru) |
EP (1) | EP1924281B1 (ru) |
JP (2) | JP5395430B2 (ru) |
KR (1) | KR101334047B1 (ru) |
CN (2) | CN101283099B (ru) |
AU (1) | AU2006278696B2 (ru) |
BR (1) | BRPI0614297A2 (ru) |
CA (1) | CA2617483C (ru) |
ES (1) | ES2728791T3 (ru) |
HU (1) | HUE043952T2 (ru) |
PL (1) | PL1924281T3 (ru) |
RU (3) | RU2480480C2 (ru) |
SG (1) | SG2014007934A (ru) |
UA (1) | UA94717C2 (ru) |
WO (1) | WO2007019094A2 (ru) |
ZA (1) | ZA200800505B (ru) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
BRPI0617952A2 (pt) | 2005-10-28 | 2011-08-09 | Boehringer Ingelheim Vetmed | composição antigênica compreendendo um antìgeno de um patógeno de um animal de uma primeira espécie, bem como uso de vacinas para o tratamento/prevenção da transmissão de patógenos da gripe entre espécies |
CA2660038A1 (en) * | 2006-08-14 | 2008-06-19 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
CN101687921A (zh) * | 2007-05-11 | 2010-03-31 | 淡马锡生命科学研究院有限公司 | 可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白 |
HUE029921T2 (en) * | 2007-06-25 | 2017-04-28 | The Administrators Of The Tulane Educational Fund | Flu-inhibiting preparations and methods |
CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
PT2610345E (pt) | 2007-11-27 | 2016-01-11 | Medicago Inc | Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina |
CN103990120B (zh) * | 2008-04-01 | 2018-06-05 | 伊耐特免疫治疗有限公司 | 抗感染剂及其用途 |
WO2010006452A1 (en) * | 2008-07-18 | 2010-01-21 | Medicago Inc. | New influenza virus immunizing epitope |
PL2358386T3 (pl) * | 2008-11-28 | 2017-04-28 | Statens Serum Institut | Zoptymalizowane szczepionki na grypę |
KR101145720B1 (ko) * | 2009-06-23 | 2012-05-14 | 한밭대학교 산학협력단 | 안전성이 뛰어난 인플루엔자 바이러스 백신용 재조합 헤마글루티닌 단백질을 함유하는 생분해성 plga 미립자의 제조 방법 |
ES2669303T3 (es) | 2009-06-24 | 2018-05-24 | Medicago Inc. | Partículas pseudovíricas quiméricas de influenza que comprenden hemaglutinina |
SG10201403557QA (en) * | 2009-06-25 | 2014-10-30 | Medimmune Llc | Swine influenza hemagglutinin variants |
PT3354657T (pt) | 2009-09-22 | 2022-05-06 | Medicago Inc | Método de preparação de proteínas derivadas de plantas |
CN102095852A (zh) * | 2010-11-24 | 2011-06-15 | 中国检验检疫科学研究院 | 一种用于快速检测新型h1n1流感病毒的双抗体夹心法 |
TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
DK2760882T3 (da) * | 2011-09-30 | 2023-07-03 | Medicago Inc | Forøgelse af udbyttet af viruslignende partikler i planter |
CA2871160C (en) | 2012-05-10 | 2023-03-14 | Massachusetts Institute Of Technology | Agents for influenza neutralization |
EA033027B1 (ru) * | 2012-07-17 | 2019-08-30 | Мериал, Инк. | Ослабленные вакцины от свиного гриппа и способы их получения и применения |
KR101315273B1 (ko) * | 2012-10-29 | 2013-10-08 | 대한민국 | 강독화된 인플루엔자 바이러스 변이주 |
CN104491463A (zh) * | 2014-11-18 | 2015-04-08 | 四川金堂海纳生物医药技术研究所 | 一种治疗舌溢血(舌衄)的汤剂药物及制备方法 |
WO2016090297A1 (en) * | 2014-12-04 | 2016-06-09 | The New York Stem Cell Foundation | Perfusion bioreactor |
JOP20190088A1 (ar) * | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
US20180128545A1 (en) | 2016-11-08 | 2018-05-10 | Berry Metal Company | Modular furnace cooling wall |
WO2021226533A1 (en) | 2020-05-08 | 2021-11-11 | Academia Sinica | Chimeric influenza vaccines |
TW202334429A (zh) | 2021-10-01 | 2023-09-01 | 中央研究院 | Sars-cov-2棘蛋白特異性抗體及其用途 |
CN117229370A (zh) * | 2022-06-08 | 2023-12-15 | 中科南京生命健康高等研究院 | H5n6禽流感广谱性疫苗的开发及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
EP0974660A1 (en) | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
IL127331A0 (en) | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
WO2004112831A2 (en) * | 2003-05-28 | 2004-12-29 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines and gene therapy |
CN1261564C (zh) * | 2003-12-02 | 2006-06-28 | 中国农业科学院哈尔滨兽医研究所 | 人工重组的流感病毒及其应用 |
US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
-
2006
- 2006-07-27 US US11/460,584 patent/US7871626B2/en active Active
- 2006-07-28 SG SG2014007934A patent/SG2014007934A/en unknown
- 2006-07-28 BR BRPI0614297-4A patent/BRPI0614297A2/pt not_active Application Discontinuation
- 2006-07-28 ES ES06813248T patent/ES2728791T3/es active Active
- 2006-07-28 AU AU2006278696A patent/AU2006278696B2/en active Active
- 2006-07-28 WO PCT/US2006/029575 patent/WO2007019094A2/en active Application Filing
- 2006-07-28 HU HUE06813248A patent/HUE043952T2/hu unknown
- 2006-07-28 KR KR1020087005408A patent/KR101334047B1/ko active IP Right Grant
- 2006-07-28 PL PL06813248T patent/PL1924281T3/pl unknown
- 2006-07-28 UA UAA200802674A patent/UA94717C2/ru unknown
- 2006-07-28 JP JP2008525063A patent/JP5395430B2/ja active Active
- 2006-07-28 CA CA2617483A patent/CA2617483C/en active Active
- 2006-07-28 RU RU2011103648/10A patent/RU2480480C2/ru active
- 2006-07-28 CN CN2006800372900A patent/CN101283099B/zh active Active
- 2006-07-28 EP EP06813248.9A patent/EP1924281B1/en active Active
- 2006-07-28 RU RU2008107875/10A patent/RU2420535C2/ru active
- 2006-07-28 CN CN201310049997.5A patent/CN103172710B/zh active Active
-
2008
- 2008-01-17 ZA ZA200800505A patent/ZA200800505B/xx unknown
-
2010
- 2010-12-09 US US12/964,491 patent/US8293247B2/en active Active
-
2012
- 2012-09-13 US US13/614,835 patent/US8574592B2/en active Active
-
2013
- 2013-01-11 RU RU2013101020/10A patent/RU2552213C2/ru active
- 2013-09-04 JP JP2013183196A patent/JP5745584B2/ja active Active
- 2013-10-03 US US14/045,097 patent/US9499850B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013101020A (ru) | Вакцины на основе модифицированного вируса гриппа | |
ES2563646T3 (es) | Composiciones y métodos relacionados con variantes de la proteína A (SpA) | |
BRPI0923599A2 (pt) | vírus da febre suína clássica recombinante, vacina para febre suína clássica viva, métodos para proteger um animal contra a febre suína clássica, para diferenciar animais infectados com o vírus da febre suína clássica de animais não infectados ou de animais vacinados com a vacina para febre suína clássica, e para isolar um vírus da febre suína clássica recombinante infeccioso, molécula de cdna, uso do vírus da febre suína clássica recombinante infeccioso, e, elisa com base em peptídeo | |
DK1881845T3 (da) | Nipah-virusvacciner | |
EA201270063A1 (ru) | Рекомбинантные антигены pcb | |
MXPA05009580A (es) | Vacuna contra el virus de la influenza. | |
RU2008119501A (ru) | Функциональные вирусоподоюные частицы гриппа (vlps) | |
EA200970013A1 (ru) | Вакцинация против гриппа по схеме многократного введения с использованием безадъювантной дозы | |
EA201491754A1 (ru) | Вакцина против rsv | |
RS53723B1 (en) | HUMAN VIRUS VIRUS, ASSOCIATED WITH ITS PREPARATION AND PROCEDURES | |
BRPI0208183B8 (pt) | peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer | |
EA200801756A1 (ru) | Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса | |
WO2007067517A3 (en) | Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants | |
EA200801251A1 (ru) | Вакцины против гриппа, адсорбированные на алюминиевых адъювантах, для немедленного приёма | |
NZ627888A (en) | Materials and methods for respiratory disease control in canines | |
PE20211469A1 (es) | Proteinas f de prefusion del vrs estabilizadas | |
ATE547118T1 (de) | Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung | |
EP2078083A4 (en) | NEW DOG INFLUENZA VIRUS AND VEGETABLE THEREFOR | |
RU2006113251A (ru) | Штамм вируса гриппа а/17/утка/потсдам/86/92(h5n2) для производства живой и инактивированной гриппозной вакцины | |
RU2012120671A (ru) | Рекомбинантный человеческий белок сс10 для лечения гриппа | |
EA201500643A1 (ru) | Парвовирус свиней 5а, способы применения и вакцина | |
AR047581A1 (es) | Vacunas de calicivirus felino | |
EA201500837A1 (ru) | Парвовирус свиней 5в, способы применения и вакцина | |
RU2007127098A (ru) | Холодоадаптированный штамм вируса гриппа а/краснодар/101/59/35(h2n2) для получения реассортантных штаммов живой гриппозной вакцины | |
EA200301151A1 (ru) | Вакцина против натуральной оспы |